Rallybio Corporation

NASDAQ:RLYB

Biotechnology

Healthcare
$15.52 +0.03%

+$0.01 today

Market cap
$83.56M
Beta
-0.88
P/E (TTM)
-11.6
EPS (TTM)
-$1.37
52W Low $2.40High $17.57

Volume 0.04M

Average 0.25M

Returns on capital

Rallybio Corporation management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-15.5%

avg -52.8%

ROIC

-48.3%

avg -57.6%

ROA

-14.4%

avg -46.7%

Analysis

ROA is currently the strongest return metric at -14.4% versus its period average of -46.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Stephen Uden

Co-Founder, President, Chief Executive Officer & DirectorUSD 857.98K680<0.01%

Jonathan I. Lieber

Chief Financial Officer & TreasurerUSD 645.49K560<0.01%

Martin W. MacKay

Co-Founder & ChairmanUSD 290K70——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 2, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

14

$4.23M

Sells

2

$13,600.30

Net Transaction Value

+$4.22M

Net buying

Most Active

ADAR1 Capital Management, LLC

14 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Oct 27, 26

Lieber Jonathan I

Direct

Sell$9.6K
May 19, 26

ADAR1 Capital Management, LLC

Indirect

Buy$2.8K
May 19, 26

ADAR1 Capital Management, LLC

Indirect

Buy$139.8K
May 18, 26

ADAR1 Capital Management, LLC

Indirect

Buy$84K
May 15, 26

ADAR1 Capital Management, LLC

Indirect

Buy$2.8K
May 15, 26

ADAR1 Capital Management, LLC

Indirect

Buy$1.4K
May 13, 26

ADAR1 Capital Management, LLC

Indirect

Buy$1.1M
May 13, 26

ADAR1 Capital Management, LLC

Indirect

Buy$56.3K
May 12, 26

ADAR1 Capital Management, LLC

Indirect

Buy$11.1K
May 11, 26

ADAR1 Capital Management, LLC

Indirect

Buy$278.6K

1–10 of 16

Summary

Insiders reported 14 buys worth $4.23M and 2 sells worth $13,600.30 over the last 12 months. That adds up to net buying of $4.22M. ADAR1 Capital Management, LLC was the most active insider with 14 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
+219.1% (4yr)1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Forward estimates point to Revenue at +219.1% (4yr), giving you a quick read on expected growth from here.

Competitors

Who does Rallybio Corporation compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about RLYB's management, answered from reported figures.

Who manages RLYB?

Rallybio Corporation (RLYB) lists 3 active executives. The top listed executive is Stephen Uden, Co-Founder, President, Chief Executive Officer & Director.

Are RLYB insiders buying or selling?

Recent insider activity shows net buying of $63.08M.